2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Pituitary ACTH Hypersecretion: new trials by email Literature Review of Pituitary ACTH Hypersecretion trials Research Report on Pituitary ACTH Hypersecretion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Lu AG13909 in Adult Participants With Cushing's Disease Lu AG13909 - Cushing's Disease | Phase 2 | Active not recruiting | H. Lundbeck A/S | 16 | 2024-06-19 | 2026-10-16 |
| Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome relacorilant - Cushing Syndrome | Phase 2 | Active not recruiting | Corcept Therapeutics | 125 | 2018-05-07 | 2026-10-09 |
ACTH Syndrome, Ectopic (1) · Adrenal Cortex Neoplasms (1) · Adrenocortical Carcinoma (1) · Cushing Syndrome (1) · Diabetes Mellitus, Type 2 (1) · Hypertension (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Endocrine System Diseases (2) · Hyperpituitarism (2) · Hypothalamic Diseases (2) · Nervous System Diseases (2) · Pituitary Diseases (2) · Adenocarcinoma (1) · Adrenal Cortex Diseases (1) · Adrenal Gland Diseases (1) · Adrenal Gland Neoplasms (1) · Adrenocortical Hyperfunction (1) · Carcinoma (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1)
relacorilant (1)
Corcept Therapeutics (1) · H. Lundbeck A/S (1)
Italy (2) · Poland (2) · Romania (2) · Spain (2) · United States (2) · Austria (1) · Canada (1) · France (1) · Georgia (1) · Germany (1) · Hungary (1) · Israel (1) · Netherlands (1) · United Kingdom (1)
John McNally (1)
2023 (1)